Treatment history of XDR M. tuberculosis isolates.

Note: All isolates were pulmonary TB patients.*The patients were on treatment with enlisted drugs at the time of sample collection.**The patients were on treatment with enlisted drugs after providing DST report.MDR-TB = Multi Drug Resistant Tuberculosis, KM = Kanamycin, PZA = Pyrazinamide, ETA = Ethionamide, PAS = Para Amino salicylic acid, LVF = Levofloxacin, D-CS = D-cycloserine, AX = Amoxicillin, ETH = Ethambutol, CAP = Capreomycin, CFZ = Clofazimine, CLARI = Clarithromycin, MOX = Moxifloxacin, INH = Isoniazid, NA = not available, NH = No history.注：所有分离菌株均来自肺结核（pulmonary TB）患者。* 样本采集时，患者正接受所列药物的治疗。** 患者在获取药物敏感性试验（DST, Drug Susceptibility Test）报告后，仍在接受所列药物的治疗。其中：耐多药结核病（Multi Drug Resistant Tuberculosis，简称MDR-TB）、卡那霉素（Kanamycin，简称KM）、吡嗪酰胺（Pyrazinamide，简称PZA）、乙硫异烟胺（Ethionamide，简称ETA）、对氨基水杨酸（Para Amino salicylic acid，简称PAS）、左氧氟沙星（Levofloxacin，简称LVF）、D-环丝氨酸（D-cycloserine，简称D-CS）、阿莫西林（Amoxicillin，简称AX）、乙胺丁醇（Ethambutol，简称ETH）、卷曲霉素（Capreomycin，简称CAP）、氯法齐明（Clofazimine，简称CFZ）、克拉霉素（Clarithromycin，简称CLARI）、莫西沙星（Moxifloxacin，简称MOX）、异烟肼（Isoniazid，简称INH）；NA表示无可用数据（not available），NH表示无病史（No history）。